Contact

Representative before the EPO

Employment test 51 - 200 employees
Company dna maiwald patentanwalts gmbh
operating since 1995
Headquarter in Munich and 4 offices
active in Legal Services and IP Consulting

Andreas Ledl has worked on the following 9 EPO patent applications which have been published in the last five years:

EP13748684

THERMOSENSITIVE NANOPARTICLE FORMULATIONS AND METHOD OF MAKING THE SAME

IPC classification:
A61K 9/127
Applicant:
Celsion Corporation
Agent:
Andreas Ledl, Maiwald Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP13722381

INTRA-OPERATIVE CANCER DIAGNOSIS BASED ON A HYPERPOLARIZED MARKER

IPC classification:
G01N 33/574
Agent:
Andreas Ledl, Maiwald Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP13786679

SUBSTITUTED TRICYCLIC BENZIMIDAZOLES AS KINASE INHIBITORS

IPC classification:
A61K 31/4188, C07D 471/06, C07D 487/06
Agent:
Andreas Ledl, Maiwald Patentanwalts GmbH
Status:
PATENT GRANTED
EP13815453

PREDICTION OF THE TREATMENT RESPONSE TO AN ANTI-EGFR MOLECULE IN COLORECTAL CANCER PATIENTS

IPC classification:
C12Q 1/68
Applicant:
Graz University of Medicine (Medizinische Universit├Ąt Graz)
Agent:
Andreas Ledl, Maiwald Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP15180143

DOSAGE FORM CONTAINING OXYCODONE AND NALOXONE

IPC classification:
A61K 9/28, A61K 31/485, A61P 25/04
Applicant:
Euro-Celtique S.A.
Agent:
Andreas Ledl, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP14705370

PYRIDINE DERIVATIVES AS 5-HT6 RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/444, A61P 25/00, C07D 405/06, C07D 405/14
Agent:
Andreas Ledl, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP11802440

A COMBINATION OF AN OPIOID AGONIST AND AN OPIOID ANTAGONIST IN THE TREATMENT OF PARKINSON'S DISEASE

IPC classification:
A61K 9/00, A61K 9/14, A61K 9/16, A61K 9/20, A61K 9/28, A61K 31/485, A61K 45/06, A61P 1/10, A61P 25/00, A61P 25/02, A61P 25/14, A61P 25/16
Applicant:
Euro-Celtique S.A.
Agent:
Andreas Ledl, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP14832793

VACCINE FORMULATIONS THAT INDUCE A TH2 IMMUNE RESPONSE

IPC classification:
A61K 39/00, A61P 25/28, B01F 17/56
Agent:
Andreas Ledl, Maiwald Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP15839303

SWEETNESS ENHANCER

IPC classification:
C07C 39/10
Applicant:
PepsiCo Inc
Agent:
Andreas Ledl, Maiwald Patentanwalts GmbH
Status:
Request for examination was made

Please Sign in to use this feature